https://doi.org/10.55788/7552c1ed
PCTs are pivotal in dialysis care. They operate haemodialysis machines with prescribed treatment parameters, manage cannulation, and monitor vitals. Turnover and variation in the number of PCTs on site can compromise consistent, high-quality care.
Dr Laura Plantinga (Emory University, GA, USA) presented the results of a retrospective cohort study that assessed the association of patient:PCT ratios with health outcomes within 1 year of starting in-centre haemodialysis [1]. The data was accessed from the United States Renal Data System (USRDS), and it included 200,863 patients who started in-centre haemodialysis from 2016β2019 and received haemodialysis for a minimum of 90 days. The mean age was 63 years. Patient:PCT ratio was calculated by dividing the total number of patients receiving in-centre haemodialysis by the number of full-time equivalent PCTs reported on the last day of the year prior. Outcomes included mortality, first transplantation, first all-cause hospitalisation, and first hospitalisation caused by sepsis, fluid overload, or vascular access.
The quartile of patients with the highest patient:PCT ratio had an increased incidence of mortality (IRR 1.07; 95% CI 1.02β1.12; P<0.001), all-cause hospitalisation (IRR 1.05; 95% CI 1.02β1.08; P<0.001), fluid overload hospitalisation (IRR 1.05; 95% CI 1.02β1.08; P<0.001), sepsis hospitalisation (IRR 1.08; 95% CI 1.03β1.14; P<0.001), and vascular access hospitalisation (IRR 1.15; 95% CI 1.03β1.28; P<0.001). Overall, this quartile had a decreased incidence of transplantation (IRR 0.80; 95% CI 0.71β0.91; P<0.001).
Dr Plantinga concluded that βdialysis PCTs may play an important β and often overlooked β role in the quality of care delivered to US patients receiving in-centre haemodialysis. Increased PCT patient loads may result in worse patient outcomes.β
- Plantinga L, et al. Higher Patient-to-Patient Care Technician Ratios Associated with Worse Outcomes Among US In-Center Hemodialysis Patients. TH-OR45, ASN Kidney Week 2023, 2β5 November, Philadelphia, PA, USA.
Copyright Β©οΈ2023 Medicom Medical Publishers
Posted on
Previous Article
« Haemodiafiltration increases longevity compared with haemodialysis, but does it improve patient satisfaction? Next Article
New approaches to successful vascular access »
« Haemodiafiltration increases longevity compared with haemodialysis, but does it improve patient satisfaction? Next Article
New approaches to successful vascular access »
Table of Contents: ASN 2023
Featured articles
Patient care technicians improve haemodialysis patient outcomes
Sparsentan outperforms irbesartan for treatment of IgAN
Chronic Kidney Disease
Aldosterone synthase inhibition reduces albuminuria in CKD
Low doses of zibotentan with dapagliflozin improve albuminuria in patients with CKD
Spironolactone failed to reduce major adverse cardiac effects in patients with CKD on haemodialysis
Efficacy of bardoxolone methyl for DKD, without increased cardiac risk
Renal Replacement Therapy
New approaches to successful vascular access
Patient care technicians improve haemodialysis patient outcomes
Donor stem cells may reduce lifelong immunosuppressant use following transplant surgery
A systems approach to kidney transplantation disappoints
Glomerular Disease
Obinutuzumab attenuates kidney decline in lupus nephritis
Clinical benefits of sparsentan for patients with FSGS
Sparsentan outperforms irbesartan for treatment of IgAN
Rare or Genetic Kidney Disease
Small molecule PGE1 shows promise for nephronophthisis treatment in vitro and in vivo
Related Articles
Β© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com